insights_auto
Zašto je EDIT pao 4,09%?
Istražite detaljnijechevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 USD
arrow_downward
−4,09%(−0,070) 1D
1,66 USD
arrow_upward
+1,22% (+0,020)bedtimeNakon radnog vremena
Zatvoreno: 20. stu, 16:00:00 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Otvori
1,69 USD
Najviša
1,78 USD
Najniža
1,63 USD
Trž. kap.
253,12 mil.
Prosj. kol.
2,24 mil.
Količina
2,68 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,63 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Otvori
1,69 USD
Najviša
1,78 USD
Najniža
1,63 USD
Trž. kap.
253,12 mil.
Prosj. kol.
2,24 mil.
Količina
2,68 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,63 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
Yahoo Finance
·
prije 1 sat
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
prije 19 minuta
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026
The Motley Fool
·
prije 2 sata
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
Beinsure
·
prije 11 sati
Dow Jones today: What’s next for stocks in 2027 after an 8% weekly crash?
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com